Risk Factors for Bleeding Events with Enoxaparin, Dabigatran and Fondaparinux in Hospitalized Patients with Varying Levels of Renal Impairment

Ahuja, Tania; Altshuler, Jerry; Papadopoulos, John

doi:10.4172/2376-0419.1000178

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Retroperitoneal hemorrhage constitutes 1% of all adverse bleeding events [4]. ough more common in patients with renal impairment, the rarity of rectus sheath and retroperitoneal hematomas makes well-established conclusions difficult [5,6].…”

Section: Discussionmentioning

confidence: 99%

Fatal Retroperitoneal Hematoma in a Patient Receiving Enoxaparin for Bilateral Pulmonary Emboli

Sexe

McCarthy

Dara

et al. 2020

Case Reports in Hematology

View full text Add to dashboard Cite

Venous thromboembolism occurs when a deep vein thrombosis travels to the lungs and forms a pulmonary embolism. Low-molecular-weight heparins are a mainstay in the treatment and prevention of venous thromboembolism and should be initiated promptly due to substantial morbidity and mortality. A rare side effect of low-molecular-weight heparins is major bleeding, which also carries a significant morbidity and mortality rate. Here, we present a case of a fatal retroperitoneal hematoma in a patient being treated with enoxaparin for bilateral pulmonary emboli.

show abstract

Section: Discussionmentioning

confidence: 99%